.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
Express Scripts
QuintilesIMS
Medtronic
Johnson and Johnson
Accenture
Julphar
Healthtrust
Moodys

Generated: January 21, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 2004-048928

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Arbor Pharms LlcEDARBIazilsartan kamedoxomilTABLET;ORAL200796-001Feb 25, 2011RXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION
Arbor Pharms LlcEDARBIazilsartan kamedoxomilTABLET;ORAL200796-002Feb 25, 2011RXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION
Arbor Pharms LlcEDARBYCLORazilsartan kamedoxomil; chlorthalidoneTABLET;ORAL202331-001Dec 20, 2011RXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION
Arbor Pharms LlcEDARBYCLORazilsartan kamedoxomil; chlorthalidoneTABLET;ORAL202331-002Dec 20, 2011RXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION
Arbor Pharms LlcEDARBIazilsartan kamedoxomilTABLET;ORAL200796-001Feb 25, 2011RXYesNo➤ Subscribe➤ SubscribeY
Arbor Pharms LlcEDARBIazilsartan kamedoxomilTABLET;ORAL200796-002Feb 25, 2011RXYesYes➤ Subscribe➤ SubscribeY
Arbor Pharms LlcEDARBYCLORazilsartan kamedoxomil; chlorthalidoneTABLET;ORAL202331-001Dec 20, 2011RXYesNo➤ Subscribe➤ SubscribeY
Arbor Pharms LlcEDARBYCLORazilsartan kamedoxomil; chlorthalidoneTABLET;ORAL202331-002Dec 20, 2011RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist